Statera Biopharma, Inc. (STAB)
OTCMKTS · Delayed Price · Currency is USD
0.0004
+0.0002 (100.00%)
At close: Feb 10, 2026
Statera Biopharma Market Cap
Statera Biopharma has a market cap or net worth of $29.03 thousand as of February 10, 2026. Its market cap has increased by 100.00% in one year.
Market Cap
29.03K
Enterprise Value
n/a
Revenue
3.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since July 28, 2021, Statera Biopharma's market cap has decreased from 170.15M to 29.03K, a decrease of -99.98%. That is a compound annual growth rate of -85.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 14.52K | -33.33% |
| Dec 31, 2025 | 21.78K | 200.01% |
| Dec 31, 2024 | 7.26K | -83.33% |
| Dec 29, 2023 | 43.55K | -99.02% |
| Dec 30, 2022 | 4.44M | -93.99% |
| Dec 31, 2021 | 73.82M | -56.61% |
| Jul 28, 2021 | 170.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syros Pharmaceuticals | 21.47K |
| America Great Health | 21.15K |
| Health Sciences Group | 20.51K |
| Regenicin | 15.35K |
| Virpax Pharmaceuticals | 13.30K |
| Ampio Pharmaceuticals | 11.35K |
| Aridis Pharmaceuticals | 10.66K |
| Trevena | 10.64K |